Francisco
Blanco García
Hospital Universitario de la Princesa
Madrid, EspañaPublications in collaboration with researchers from Hospital Universitario de la Princesa (55)
2024
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
-
Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting
Reumatologia Clinica, Vol. 18, Núm. 10, pp. 567-573
-
Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis
eBioMedicine, Vol. 80
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
-
Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
BMC Musculoskeletal Disorders, Vol. 22, Núm. 1
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study
Arthritis Care and Research, Vol. 72, Núm. 6, pp. 822-828
2019
-
A combined transcriptomic and genomic analysis identifies a gene signature associated with the response to anti-TNF therapy in rheumatoid arthritis
Frontiers in Immunology, Vol. 10, Núm. JUL
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
-
Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin
Cells, Vol. 9, Núm. 1
2017
-
Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts
Medicine (United States), Vol. 96, Núm. 26
-
Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Arthritis and Rheumatology, Vol. 69, Núm. 1, pp. 77-85
-
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, singleblind, placebo-controlled phase Ib/IIa clinical trial
Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 196-202
-
Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3
-
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
PLoS ONE, Vol. 12, Núm. 9
-
Recommendations by the Spanish Society of Rheumatology for the management of patients diagnosed with rheumatoid arthritis who cannot be treated with methotrexate
Reumatologia Clinica, Vol. 13, Núm. 3, pp. 127-138
2016
-
A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis
Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1106-1111
-
A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis
Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 147-150
-
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344